These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 1985074)
21. An eosinophilia-myalgia syndrome associated with an L-tryptophan containing product. Saag KG; Goldschmidt R; Vernof H; Golbus J J Rheumatol; 1990 Nov; 17(11):1551-3. PubMed ID: 2273501 [TBL] [Abstract][Full Text] [Related]
22. A histopathologic comparison of Shulman's syndrome (diffuse fasciitis with eosinophilia) and the fasciitis associated with the eosinophilia-myalgia syndrome. Feldman SR; Silver RM; Maize JC J Am Acad Dermatol; 1992 Jan; 26(1):95-100. PubMed ID: 1732344 [TBL] [Abstract][Full Text] [Related]
23. L-tryptophan-related eosinophilia-myalgia syndrome: a case report. Wong CB; Love J; Pon E; Scottolini AG; Manoukian AA Hawaii Med J; 1990 Aug; 49(8):295-8, 303. PubMed ID: 2211094 [TBL] [Abstract][Full Text] [Related]
24. Tryptophan-associated eosinophilic connective-tissue disease. A new clinical entity? Clauw DJ; Nashel DJ; Umhau A; Katz P JAMA; 1990 Mar; 263(11):1502-6. PubMed ID: 2308182 [TBL] [Abstract][Full Text] [Related]
25. [Eosinophilia-myalgia syndrome and L-tryptophan intake]. von Gizycki-Nienhaus B; Meurer M; Krieg T; Braun-Falco O Hautarzt; 1991 Mar; 42(3):179-82. PubMed ID: 1829070 [TBL] [Abstract][Full Text] [Related]
26. Eosinophilia-myalgia syndrome. Recognition of a distinct clinicopathologic entity. Gibbons RB; Metzger JR Arch Intern Med; 1990 Oct; 150(10):2175-7. PubMed ID: 2222104 [TBL] [Abstract][Full Text] [Related]
27. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use. Varga J; Griffin R; Newman JH; Jimenez SA J Rheumatol; 1991 Feb; 18(2):259-63. PubMed ID: 2023221 [TBL] [Abstract][Full Text] [Related]
29. The eosinophilia-myalgia syndrome with neuritis associated with L-tryptophan use. Dicker RM; James N; Cunha BA Ann Intern Med; 1990 Jun; 112(12):957-8. PubMed ID: 2339856 [TBL] [Abstract][Full Text] [Related]
31. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. Hertzman PA; Blevins WL; Mayer J; Greenfield B; Ting M; Gleich GJ N Engl J Med; 1990 Mar; 322(13):869-73. PubMed ID: 2314421 [TBL] [Abstract][Full Text] [Related]
33. [Eosinophilia-myalgia syndrome after L-tryptophan intake]. Zillikens D; Bammel A; Lurz C; Elsner P; Burg G Hautarzt; 1991 Mar; 42(3):154-7. PubMed ID: 2055764 [TBL] [Abstract][Full Text] [Related]
34. Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndrome. DeSchryver-Kecskemeti K; Gramlich TL; Crofford LJ; Rader JI; Page SW; Needham LL; Hill RH; Sternberg EM Mod Pathol; 1991 May; 4(3):354-7. PubMed ID: 2068062 [TBL] [Abstract][Full Text] [Related]
35. Generalized morphea with peripheral eosinophilia, fasciitis and myositis. King DF; Dore RK; Gilbert DJ; Gurevitch AW; Hirose FM Int J Dermatol; 1980 Apr; 19(3):149-53. PubMed ID: 7190134 [TBL] [Abstract][Full Text] [Related]
36. Eosinophilia-myalgia syndrome. A clinical case series of 21 patients. New Mexico Eosinophilia-Myalgia Syndrome Study Group. Philen RM; Eidson M; Kilbourne EM; Sewell CM; Voorhees R Arch Intern Med; 1991 Mar; 151(3):533-7. PubMed ID: 2001136 [TBL] [Abstract][Full Text] [Related]
37. Absent neutrophil alkaline phosphatase in the eosinophilia myalgia syndrome associated with L-tryptophan use. Jaffe JP; Gertner E; Miller W Am J Hematol; 1991 Apr; 36(4):280-1. PubMed ID: 2012075 [TBL] [Abstract][Full Text] [Related]
38. Development of diffuse fasciitis with eosinophilia during L-tryptophan treatment: demonstration of elevated type I collagen gene expression in affected tissues. A clinicopathologic study of four patients. Varga J; Peltonen J; Uitto J; Jimenez S Ann Intern Med; 1990 Mar; 112(5):344-51. PubMed ID: 2306063 [TBL] [Abstract][Full Text] [Related]